Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Netra Joshi"'
Autor:
Netra, Joshi, Julia, Löffler, Karolina, Szczesna, Tyler, Do, Minh, Vu, Jared, Cobb, Huy, Ngo, John, Nguyen, Vincenzo, Carbone, Deborah, Bergmann, Elizabeth, Shin, Tobias, Hartmann, Damien, Gruson
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 61:e13-e16
Autor:
Theodore R. Holman, Eng H. Lo, Netra Joshi, Ganesha Rai, Qiangli Zhang, Adam Yasgar, Joo Eun Jung, David J. Maloney, Giovanni Diaz, Anton Simeonov, Victor Kenyon, Yu Liu, Klaus van Leyen, Ajit Jadhav, Lena Schultz, Steve Perry
Publikováno v:
Journal of Medicinal Chemistry
A key challenge facing drug discovery today is variability of the drug target between species, such as with 12/15-lipoxygenase (12/15-LOX), which contributes to ischemic brain injury, but its human and rodent isozymes have different inhibitor specifi
Autor:
David J. Maloney, Anton Simeonov, Adam Yasgar, Giovanni Diaz, Edward H. Kerns, J. Brian Jameson, Diane K. Luci, Michael Holinstat, Theodore R. Holman, David A. Taylor-Fishwick, Kate Markham, Norine Kuhn, Ajit Jadhav, Netra Joshi, Steve Perry, Jennifer Yeung, Lena Schultz, Auric Kantz, Jerry L. Nadler
Publikováno v:
Journal of Medicinal Chemistry. 57:495-506
Human lipoxygenases (LOXs) are a family of iron-containing enzymes which catalyze the oxidation of polyunsaturated fatty acids to provide the corresponding bioactive hydroxyeicosatetraenoic acid (HETE) metabolites. These eicosanoid signaling molecule
Autor:
Klaus van Leyen, Eng H. Lo, Anton Pekcec, Joseph L. Witztum, Hulya Karatas, Theodore R. Holman, Rajiv R. Ratan, Stefanie Pallast, N. A. Smirnova, Netra Joshi, Kazim Yigitkanli, Irina G. Gazaryan, Emiri T. Mandeville, Joan Montaner
Publikováno v:
Annals of Neurology. 73:129-135
Targeting newly identified damage pathways in the ischemic brain can help to circumvent the currently severe limitations of acute stroke therapy. Here we show that the activity of 12/15-lipoxygenase was increased in the ischemic mouse brain, and 12/1
Autor:
Michael Holinstat, David A. Taylor-Fishwick, David J. Maloney, J. Brian Jameson, Jerry L. Nadler, William Leister, Michelle Armstrong, Ganesha Rai, Theodore R. Holman, Netra Joshi, James M. Bougie, Ajit Jadhav, Lena Schultz, Steve Perry, Anton Simeonov, Victor Kenyon
Publikováno v:
Journal of Medicinal Chemistry. 54:5485-5497
We report the discovery of novel small molecule inhibitors of platelet type 12-human lipoxygenase, which display nanomolar activity against the purified enzyme, using a quantitative high throughput screen (qHTS) on a library of 153,607 compounds. The
Lipoxygenases, important enzymes in inflammation, can regulate their substrate specificity by allosteric interactions with its own hydroperoxide products. In the current work, addition of both 13-(S) hydroxy-9Z,11E-octadecadienoic acid (13-(S)-HODE)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360894b0e2b1779b161f5d14d06cebb8
https://europepmc.org/articles/PMC3866584/
https://europepmc.org/articles/PMC3866584/
Autor:
Kazim Yigitkanli, Anton Pekcec, Stefanie Pallast, Emiri Mandeville, Netra Joshi, Natalya Smirnova, Irina G Gazaryan, Rajiv R Ratan, Joseph L Witztum, Theodore R Holman, Eng H Lo, Klaus Van Leyen
Publikováno v:
Stroke. 43
Background and Purpose - Acute phase stroke treatment options are currently very limited. We have previously demonstrated 12/15-lipoxygenase (12/15-LOX) to initiate an apoptotic cell death cascade, contributing to neuronal cell death, but also vascul